Literature DB >> 15034741

Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.

Stefan Corvin1, Markus Kuczyk, Aristotelis Anastasiadis, Arnulf Stenzl.   

Abstract

Retroperitoneal lymph node dissection (RPLND) is still the most sensitive and specific method for the detection of lymph node metastases in stage I nonseminomatous testicular carcinoma. In stage II disease, residual malignant tumor and mature teratoma can be removed. Acceptance of this operation, however, has decreased due to the morbidity caused by the open approach. To reduce this morbidity, and to improve the acceptance of RPLND, laparoscopy has been introduced. Clinical data with long-term follow-up are now available which demonstrate the technical feasibility of laparoscopic RPLND. Studies comparing laparoscopy and open surgery show advantages for the laparoscopic approach in terms of reduced blood loss, intraoperative complications and operative time. Mainly minor complications, such as chylous ascites or lymphocele formation, are observed. The conversion rate to open surgery, mainly due to intraoperative bleeding, is acceptable at less than 10%. As in open surgery, antegrade ejaculation can be preserved successfully. RPLND has also been shown to provide adequate oncological results. In stage I disease, lymph node metastasis is found in 25-41% of cases. Patients with histologically proven retroperitoneal tumor receive adjuvant chemotherapy whereas individuals without evidence of retroperitoneal disease do not require additional treatment. Follow-up controls in both groups, without local recurrence, demonstrate the excellent diagnostic accuracy of this procedure. Meanwhile laparoscopic RPLND has also been introduced successfully in the management of stage II disease. Small volume residual tumors can be removed with an acceptable complication rate. However, this operation is technically demanding and should be performed only at institutions with considerable laparoscopic experience. In conclusion, laparoscopic RPLND is a safe method for low-stage germ cell tumors with minimal invasiveness and excellent clinical results. Thus laparoscopy might contribute to a better acceptance of RPLND.

Entities:  

Mesh:

Year:  2004        PMID: 15034741     DOI: 10.1007/s00345-004-0400-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  26 in total

1.  Laparoscopic retroperitoneal lymph node dissection: description of the nerve-sparing technique.

Authors:  Reinhard Peschel; Matthew T Gettman; Richard Neururer; Alfred Hobisch; Georg Bartsch
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

Review 2.  Port site metastases in urological laparoscopic surgery.

Authors:  Alexander Tsivian; A Ami Sidi
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

3.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome.

Authors:  G Janetschek; A Hobisch; R Peschel; A Hittmair; G Bartsch
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

4.  Clinical stage I testis cancer: long-term outcome of patients on surveillance.

Authors:  P C Sogani; M Perrotti; H W Herr; W R Fair; H T Thaler; G Bosl
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

5.  Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer.

Authors:  J J Rassweiler; T Frede; E Lenz; O Seemann; P Alken
Journal:  Eur Urol       Date:  2000-03       Impact factor: 20.096

6.  Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors.

Authors:  J B Nelson; R N Chen; J T Bishoff; W K Oh; P W Kantoff; R C Donehower; L R Kavoussi
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

7.  Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.

Authors:  M H Cullen; S P Stenning; M C Parkinson; S D Fossa; S B Kaye; A H Horwich; S J Harland; M V Williams; R Jakes
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

8.  Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer.

Authors:  N N Stone; R N Schlussel; R L Waterhouse; P Unger
Journal:  Urology       Date:  1993-11       Impact factor: 2.649

9.  Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?

Authors:  S D Fosså; H Qvist; A E Stenwig; H H Lien; S Ous; K E Giercksky
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

10.  Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysis.

Authors:  Kenneth Ogan; Yair Lotan; Kenneth Koeneman; Margaret S Pearle; Jeffrey A Cadeddu; Jens Rassweiler
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.